Inventor · disambiguated record
Philippe Hammel
Also filed as: HAMMEL PHILIPPE
3 granted patents·6 pending applications·3 citations·filing 2009–2018
57Inventor score
Top patents by PatentIndex Score
9 records- 0172US9096662B2Methods and compositions for modulation of Olfml3 mediated angiogenisisRES DEV FOUNDATION·Filed 2014·Granted Aug 4, 2015·2 cites·6 claims
- 0264US8663637B2Methods and compositions for modulation of Olfml3 mediated angiogenesisIMHOF BEAT A·Filed 2012·Granted Mar 4, 2014·1 cites·15 claims
- 0357US2011052677A1Modulation of srpx2-mediated angiogenesisRES DEV FOUNDATION·Filed 2009·Application pending·0 cites
- 0449US2018214546A1Modulation of srpx2-mediated angiogenesisRES FOUND DEV·Filed 2018·Application pending·0 cites
- 0549US2016333084A1Methods and compositions for modulation of olfml3 mediated angiogenesisRES DEV FOUNDATION·Filed 2016·Application pending·0 cites
- 0648US2013084296A1Modulation of srpx2-mediated angiogenesisRES DEV FOUNDATION·Filed 2012·Application pending·0 cites
- 0746US2015299306A1Methods and compositions for modulation of olfml3 mediated angiogenesisRES DEV FOUNDATION·Filed 2015·Application pending·0 cites
- 0845US2011287088A1Modulation of olfml-3 mediated angiogenesisIMHOF BEAT A·Filed 2009·Application pending·0 cites
- 0944US10808026B2Monoclonal Olfml-3 antibodies and uses thereofRES FOUND DEV·Filed 2014·Granted Oct 20, 2020·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Hammel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →